Each year, approximately 13,000 people are diagnosed with a primary brain tumour
The Department of Health and Social Care (DHSC) has issued a major update after thousands complained about the current state of brain cancer treatment in the UK. Its message responds to an ongoing petition, now signed by over 20,000 people, calling for increased funding efforts.
Brain tumours are currently the biggest cancer killers of children and adults under 40 in the UK, according to the Brain Tumour Charity. Around 13,000 people are diagnosed each year with a primary brain tumour, including 900 children and young people.
Given these statistics, the parliamentary campaign pressed the Government to examine increased funding to ‘give patients a fighting chance’. It contended that ‘treatments haven’t changed in decades’ and advocated for expanded exploratory research initiatives.
In response, the DHSC also agreed that ‘more needs to be done’ and stated that a National Cancer Plan is due to be published later in the year. Its message, published on October 3, read: “Every brain cancer diagnosis has life-changing impact on patients and their families. Research is vital to ensure people can get the most effective cutting-edge treatments and highest quality care.
“Between 2018/19 and 2023/24, the Department of Health and Social Care, via the National Institute for Health and Care Research (NIHR) directly invested £11.8 million in research projects and programmes focused on brain tumours.
“NIHR’s wider investments in research infrastructure are estimated to be £37.5 million, supporting the delivery of 261 brain tumour research studies and enabling over 11,400 people to participate in potentially life-changing brain tumour research. However, we understand that more needs to be done to boost research into brain tumours.”
The DHSC claimed that it is now ‘working closely’ with patient and research communities to ‘stimulate high-quality research applications’. This has involved establishing a national Brain Tumour Research Consortium and a dedicated funding call.
However, it stressed that there are ‘no plans’ to introduce a ‘Right to Try’ initiative for new treatments. In the US, the Right to Try Act permits eligible patients with life-threatening conditions to obtain unapproved investigational treatments under certain conditions.
READ MORE: NHS dental appointments are free for specific people – full list explained
The DHSC’s response continued: “Regarding new and personalised treatments, the government is committed to securing patient access to effective and innovative new medicines, including for brain tumours. There are established routes to support timely access for NHS patients to safe and clinically- and cost-effective new medicines and there are no plans to introduce a new Right to Try initiative for new treatments.
“The National Institute for Health and Care Excellence (NICE) evaluates all new medicines and makes recommendations for the NHS on whether they should be routinely funded by the NHS. NICE aims wherever possible to issue guidance on new medicines close to the point of licensing and our Life Sciences Sector Plan published in July sets out the measures we are taking to streamline decision making to accelerate patient access to new medicines by three to six months.
“The NHS in England is required to fund medicines recommended by NICE, and NHS England funds cancer medicines from the point of positive draft NICE guidance, accelerating patient access by around five months on average.”
Beyond this, the department added: “In terms of future publications, the National Cancer Plan, due to be published later this year, will have patients at its heart and will cover the entirety of the cancer pathway, from referral and diagnosis to treatment and aftercare.
“It will seek to improve every aspect of cancer care, to improve the experience and outcomes for people with cancer. Our goal is to reduce the number of lives lost to cancer over the next ten years, including for brain cancer.”
The petition entitled ‘Invest in brain cancer and give rights – turn terminal into treatable’ has currently drawn in more than 20,000 signatures. If it surpasses 100,000, it will be considered for a debate in Parliament.
You can view the petition in full here.